Partner with Us

Partners

Why Partner With DHR Health Institute For Research And Development For Clinical Research?

We, at DHR Health Institute for Research and Development recognized that an industry-wide, collaborative effort was needed to provide the latest and most promising treatments to our patients in the Rio Grande Valley. Our patient population suffers from key chronic illnesses including Diabetes, Obesity, Cardiovascular Diseases, Non-alcoholic Fatty Liver Disease, Cancers and others.

Since its inception, the DHR Health Institute for Research and Development has successfully enrolled over 1000 patients in clinical research studies across several therapeutic areas and continues to seek productive collaborations with key thought leaders in both industry and academic research settings. The increase in patient enrollment is testament to our commitment to increasing participation of the Latino community in clinical trials, both interventional and non-interventional.

Our clinical trial unit (CTU) is coordinated by highly qualified study coordinators with vast experience in this arena of clinical research. We deliver high quality data to our partners and consistently maintain the safety of all our clinical trial participants.

Our focus is on the three following milestones to ensure that we are valuable to our partners:

Why select our site to conduct your clinical trial?

  • Delivery of quality data throughout clinical trial
  • Stable patient population
  • > 90% Hispanic population with a majority Mexican descent
  • Rapid turnaround time for study-start up documentations
  • Rapid response to sponsor queries
  • State of the art facilities to meet all clinical trial specifications
  • Robust patient recruitment, enrollment and retentions strategies

Clinical Trial Support (CTU)

Our CTU has the capabilities to successfully support the following range of clinical trials:

  • Phases: I, II, III, and IV
  • Types: Diagnostic, Proof of Concept, Safety, Nutrition, Prevention, Intervention
Our physician investigators have vast experience in the following areas of clinical research:
  • Non-alcoholic fatty liver disease and Non-alcoholic steatosis hepatitis (NAFLD/NASH)
  • Cardiovascular Disease
  • Diabetes/Diabetic Nephropathy and Retinopathy
  • Metabolic Diseases
  • Neurosciences (Stroke, Movement Disorders, Epilepsy, etc.)
  • Oncology (Medical and Surgical)
  • Gastroenterology
  • Neonatology
  • Infectious Disease
  • Physical Medicine & Rehabilitation
Other Support and Ancillary Services:
  • Experienced Clinical Trials Team
  • Experienced Contracts and Budgets Team
  • Protocol Development and Implementation

Patient Demographics And Disease Burden

  • Greater than 90% Hispanic population of Mexican descent
  • Key chronic diseases are overwhelmingly present in our Rio Grande Valley (RGV) patient population including Diabetes, Obesity (see graphs below), and Cardiovascular disease
  • RGV patient population presents with unique pathology, medical history and varying pharmacological response to existing therapeutic regimens.

PHR11, Texas Public Health Region 11; Data obtained from the Center for Disease Control, 2016.

PHR11, Texas Public Health Region 11; Data obtained from the Center for Disease Control, 2016.

South Texas Counties

Disease Burden In RGV

The four county Rio Grande Valley has been identified as one of the most unhealthiest region in United States.

Many common determinants of health have been identified which includes poverty, poor nutrition and low education among other factors.

The overwhelming diseases identified in the Rio Grande Valley are:

  • Diabetes (both childhood and adult)
  • 25% of children in the Rio Grande Valley are identified as obese
  • 33% of children in Hidalgo county are obese
  • Cardiovascular Diseases
  • Cancers (particularly cervical cancers)
Trial Participants by Race

Unique Population Of RGV

  • Greater than 90% of the population in the Rio Grande Valley is of Hispanic heritage
  • Generations of families call the Valley home allowing for “vertical” clinical studies to be conducted across many generations
  • Residents in the Valley tend to stay allowing for uninterrupted longitudinal clinical studies to be conducted
  • A great opportunity for our industry partners to involve this unique population in clinical research addressing the current limitation of markedly low involvement of Hispanics (<1%) in clinical research.
  • Cancers (particularly cervical cancers)
  • Diseases are overwhelmingly present in our Rio Grande Valley (RGV) patient population including Diabetes, Obesity (see graphs below), and Cardiovascular disease
  • RGV patient population presents with unique pathology, medical history and varying pharmacological response to existing therapeutic regimens.

PHR11, Texas Public Health Region 11; Data obtained from the Center for Disease Control, 2016.

PHR11, Texas Public Health Region 11; Data obtained from the Center for Disease Control, 2016.

To apply for partnership offers you can contact the following:

Phone:

Email: